Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do human platelets express COX-2?

R Reiter1, U Resch, H Sinzinger

  • 1Department of Nuclear Medicine, University of Vienna, Währinger Gürtel 19-20, A-1090 Vienna, Austria.

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|June 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Passive smoking and cardiovascular risk.

Archives of internal medicine·1995
Same author

Gamma irradiation is not a novel approach to inhibit neointimal hyperplasia after arterial injury.

Stroke·1995
Same author

Arterial wall rather than platelets is responsible for diminished thrombogenicity during isradipine therapy.

Journal of cardiovascular pharmacology·1995
Same author

Evidence for lipid regression in humans in vivo performed by 123iodine-low-density lipoprotein scintiscanning.

Annals of the New York Academy of Sciences·1995
Same author

[1995 consensus guidelines for cholesterol. Society of Physicians in Vienna].

Wiener klinische Wochenschrift·1995
Same author

Atherosclerotic lesions in humans--plaque stabilization and regression.

Wiener klinische Wochenschrift·1995
Same journal

Cardiovascular safety profile of prostaglandin E and prostacyclin analogues: Clinical reports and ex vivo studies on human coronary arteries.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Specialized pro-resolving mediator (SPM)-enriched supplementation modulates inflammatory biomarkers in patients with symptomatic knee osteoarthritis: Blood plasma analysis from the GAUDI study.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Serum fatty acid distributions and prevalence of low omega-3 status in early pregnancy: A cross-sectional analysis of 26,389 samples from an omega-3 test-and-treat program.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Association of fish intake with systemic immune-inflammation index: Potential mediating role of n-3 polyunsaturated fatty acids.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer models.

Prostaglandins, leukotrienes, and essential fatty acids·2026
Same journal

Human milk omega-3 PUFA and infant neurodevelopment: Evidence and insights from indian mothers.

Prostaglandins, leukotrienes, and essential fatty acids·2026
See all related articles

This study investigated cyclooxygenase-2 (COX-2) presence in human platelets. Researchers found no detectable COX-2, suggesting its role in platelet function remains unconfirmed.

Area of Science:

  • Biochemistry
  • Platelet Biology
  • Enzymology

Background:

  • Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, are crucial for prostaglandin and thromboxane synthesis.
  • COX-1 is constitutively expressed, while COX-2 is inducible and plays a role in inflammation and other processes.
  • The presence and function of COX-2 in human platelets remain unclear.

Purpose of the Study:

  • To determine if human platelets express cyclooxygenase-2 (COX-2).
  • To investigate the potential role of COX-2 in platelet activation and function.

Main Methods:

  • Platelets were stimulated with various agonists like collagen, thrombin, and arachidonic acid (AA).
  • COX-1 and COX-2 activity was assessed by measuring thiobarbituric acid reactive substances (TBARS).

Related Experiment Videos

  • Specific COX inhibitors (acetylsalicylic acid, indomethacin, NS-398) were used to block enzyme activity.
  • Western blot analysis was employed to detect the presence of COX-1 and COX-2 proteins.

    • Main Results:

    • COX-1 was detected in platelets using western blot.
    • COX-2 was not detectable in platelets using the applied methods.
    • Thiobarbituric acid reactive substances (TBARS) were measured to assess enzyme activity, but specific COX-2 contributions could not be isolated.

    Conclusions:

    • The study failed to detect cyclooxygenase-2 (COX-2) in human platelets using western blot and functional assays.
    • The biological relevance of COX-2 in platelets, if present at very low levels, requires further investigation with more sensitive methods.